What is Febuxostat 40 mg Tablet used for?
Febuxostat 40 mg Tablet belongs to the class of medicines known as xanthine oxidase inhibitors. It works by reducing the body’s production of uric acid. Febuxostat is a medication that is used to prevent gout attacks but not to treat them once they have occurred.
When should you start taking febuxostat?
Time to take febuxostat: Take febuxostat at the same time every day. Take it early thing in the morning if possible. If you work shifts or want to take your medicine at night, talk to your doctor, nurse, or pharmacist. Febuxostat is a drug that can be taken either with or without food.
What are the Febuxostat 40 mg Tablet adverse effects?
- Pain in the arms, back, or jaw.
- Stools that are dark and tarry.
- bloodied nose.
- Pain or discomfort in the chest.
- urine that is hazy
- decreased urine frequency or volume
- Breathing that is laborious or labored. For more click here.
What effect does febuxostat have on the liver?
Although no cases of acute or chronic liver impairment have been recorded as a result of Febuxostat 40 mg Tablet, clinical experience with this drug is limited.
Is febuxostat beneficial to the kidneys?
Febuxostat has been found to be safe and effective in individuals with moderate to severe renal impairment, and there is no need to change the dose in these cases.
What is the recommended dosage of febuxostat 40?
Remember to take febuxostat every day to avoid a gout attack. It could take up to six months to fully activate. It has no impact during a gout attack, but you should continue to take it on a daily basis even if this happens.
Is it possible that febuxostat will harm your kidneys?
According to study findings published in Arthritis Research & Therapy, Febuxostat and allopurinol are linked to an increased risk of acute kidney damage (AKI).
Is febuxostat safe for people who have cardiac problems?
When Febuxostat 40 mg Tablet was first approved, warnings that it should not be used in patients with ischemic heart disease or congestive heart failure were included in the product labeling due to pre-market research that revealed it was linked to significant cardiovascular (CV) events.